MCH ADVISORY RESEARCHMain site ↗
Sector

Financials

138 companies under coverage across 16 industries.

Industries

Browse by industry


Coverage

Financials companies


Equity Research

Brighthouse Financial, Inc. (BHF)

BUY. 12-month probability-weighted target $129 (+147% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

BHFEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +158.4%
Equity Research

Everest Group Ltd (EG)

BUY. 12-month probability-weighted target $451 (+22% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

EGEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +49.7%
Equity Research

Corebridge Financial Inc. (CRBG)

BUY. 12-month probability-weighted target $54 (+60% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

CRBGEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +45.0%
Equity Research

Axa Equitable Holdings Inc (EQH)

BUY. 12-month probability-weighted target $73 (+41% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

EQHEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +36.0%
Equity Research

Euronet Worldwide Inc (EEFT)

BUY. 12-month probability-weighted target $87 (+21% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

EEFTEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +31.9%
Equity Research

Annaly Capital Management, Inc. (NLY)

HOLD. 12-month probability-weighted target $24 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

NLYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +24.7%
Equity Research

Progressive Corp (PGR)

HOLD. 12-month probability-weighted target $215 (+0% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PGREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +20.0%
Equity Research

Cincinnati Financial Corporation (CINF)

HOLD. 12-month probability-weighted target $186 (+10% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

CINFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +19.5%
Equity Research

Bank Ozk (OZK)

HOLD. 12-month probability-weighted target $50 (+1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

OZKEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +16.4%
Equity Research

Old Republic International Corp (ORI)

HOLD. 12-month probability-weighted target $41 (+0% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

ORIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +14.6%
Equity Research

MGIC Investment Corp (MTG)

HOLD. 12-month probability-weighted target $31 (+0% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

MTGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +14.5%
Equity Research

Western Alliance Bancorporation (WAL)

HOLD. 12-month probability-weighted target $80 (+0% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

WALEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +14.4%
Equity Research

Primerica Inc (PRI)

HOLD. 12-month probability-weighted target $309 (+7% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

PRIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +12.1%
Equity Research

International Bancshares Corporation (IBOC)

HOLD. 12-month probability-weighted target $78 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

IBOCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +11.8%
Equity Research

Globe Life Inc (GL)

HOLD. 12-month probability-weighted target $176 (+3% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

GLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +11.1%
Equity Research

Evercore Partners Inc (EVR)

HOLD. 12-month probability-weighted target $333 (+13% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

EVREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +10.5%
Equity Research

The Hanover Insurance Group Inc (THG)

HOLD. 12-month probability-weighted target $212 (-5% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

THGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +10.3%
Equity Research

Essent Group Ltd (ESNT)

HOLD. 12-month probability-weighted target $65 (-6% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

ESNTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +9.5%
Equity Research

T. Rowe Price Group Inc (TROW)

HOLD. 12-month probability-weighted target $111 (+2% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

TROWEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +9.2%
Equity Research

First American Corporation (FAF)

HOLD. 12-month probability-weighted target $69 (-4% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

FAFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +7.2%
Equity Research

Stifel Financial Corporation (SF)

HOLD. 12-month probability-weighted target $79 (-3% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

SFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.8%
Equity Research

Houlihan Lokey Inc (HLI)

HOLD. 12-month probability-weighted target $142 (+5% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

HLIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.7%
Equity Research

Zions Bancorporation (ZION)

HOLD. 12-month probability-weighted target $69 (+2% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ZIONEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.6%
Equity Research

Block, Inc (XYZ)

HOLD. 12-month probability-weighted target $79 (-1% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

XYZEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +5.5%
Equity Research

Selective Insurance Group, Inc. (SIGI)

HOLD. 12-month probability-weighted target $100 (+10% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SIGIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +4.9%
Equity Research

American Financial Group, Inc. (AFG)

HOLD. 12-month probability-weighted target $148 (+5% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

AFGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +3.5%
Equity Research

Raymond James Financial Inc. (RJF)

SELL. 12-month probability-weighted target $154 (-13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

RJFEquity ResearchMonte Carlo
9 September 2026Rating: SELL · +2.3%
Equity Research

Arch Capital Group Ltd. (ACGL)

HOLD. 12-month probability-weighted target $97 (+2% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

ACGLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.0%
Equity Research

Aflac Incorporated (AFL)

HOLD. 12-month probability-weighted target $122 (+6% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AFLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.7%
Equity Research

Hartford Financial Services Group (HIG)

HOLD. 12-month probability-weighted target $137 (+1% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

HIGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.5%
Equity Research

Ally Financial Inc (ALLY)

HOLD. 12-month probability-weighted target $44 (+3% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ALLYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.1%
Equity Research

Associated Banc-Corp (ASB)

HOLD. 12-month probability-weighted target $32 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ASBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.0%
Equity Research

Chubb Ltd (CB)

HOLD. 12-month probability-weighted target $334 (-1% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

CBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +0.9%
Equity Research

SLM Corp (SLM)

HOLD. 12-month probability-weighted target $25 (-4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SLMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +0.6%
Equity Research

Columbia Banking System Inc (COLB)

HOLD. 12-month probability-weighted target $33 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

COLBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +0.2%
Equity Research

Pinnacle Financial Partners, Inc. (PNFP)

HOLD. 12-month probability-weighted target $100 (-1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PNFPEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · 0.0%
Equity Research

American Express Company (AXP)

HOLD. 12-month probability-weighted target $348 (+7% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

AXPEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · 0.0%
Equity Research

East West Bancorp Inc (EWBC)

HOLD. 12-month probability-weighted target $135 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

EWBCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.8%
Equity Research

F.N.B. Corp (FNB)

HOLD. 12-month probability-weighted target $19 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FNBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.1%
Equity Research

Interactive Brokers Group Inc (IBKR)

HOLD. 12-month probability-weighted target $86 (-6% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

IBKREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.5%
Equity Research

PayPal Holdings Inc (PYPL)

SELL. 12-month probability-weighted target $45 (-16% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

PYPLEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -2.6%
Equity Research

W. R. Berkley Corp (WRB)

HOLD. 12-month probability-weighted target $69 (-1% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

WRBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -3.1%
Equity Research

Starwood Property Trust Inc (STWD)

HOLD. 12-month probability-weighted target $17 (+7% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

STWDEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -3.2%
Equity Research

Wintrust Financial Corporation (WTFC)

HOLD. 12-month probability-weighted target $161 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

WTFCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -3.9%
Equity Research

Renaissancere Holdings Ltd (RNR)

HOLD. 12-month probability-weighted target $319 (-1% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

RNREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -4.6%
Equity Research

SouthState Corporation (SSB)

HOLD. 12-month probability-weighted target $103 (-4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SSBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -4.7%
Equity Research

UMB Financial Corporation (UMBF)

HOLD. 12-month probability-weighted target $147 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

UMBFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -4.9%
Equity Research

Old National Bancorp (ONB)

HOLD. 12-month probability-weighted target $26 (+2% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ONBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.0%
Equity Research

RLI Corp (RLI)

HOLD. 12-month probability-weighted target $61 (+0% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

RLIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.0%
Equity Research

First Horizon Corporation (FHN)

HOLD. 12-month probability-weighted target $25 (+2% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FHNEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.1%
Equity Research

Glacier Bancorp Inc (GBCI)

HOLD. 12-month probability-weighted target $49 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

GBCIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.2%
Equity Research

The Allstate Corporation (ALL)

HOLD. 12-month probability-weighted target $233 (-8% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

ALLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.5%
Equity Research

Regions Financial Corporation (RF)

HOLD. 12-month probability-weighted target $31 (+2% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

RFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.8%
Equity Research

Federated Investors Inc B (FHI)

HOLD. 12-month probability-weighted target $57 (-8% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

FHIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.9%
Equity Research

Kinsale Capital Group Inc (KNSL)

HOLD. 12-month probability-weighted target $358 (-2% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

KNSLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.0%
Equity Research

Assurant, Inc. (AIZ)

HOLD. 12-month probability-weighted target $259 (-8% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

AIZEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.0%
Equity Research

Berkshire Hathaway (BRK-B)

HOLD. 12-month probability-weighted target $513 (+1% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

BRK-BEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.5%
Equity Research

Jefferies Financial Group Inc (JEF)

HOLD. 12-month probability-weighted target $54 (-3% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

JEFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.6%
Equity Research

KeyCorp (KEY)

HOLD. 12-month probability-weighted target $24 (+12% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

KEYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.6%
Equity Research

Fidelity National Financial Inc (FNF)

HOLD. 12-month probability-weighted target $52 (+16% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

FNFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.7%
Equity Research

Commerce Bancshares Inc (CBSH)

HOLD. 12-month probability-weighted target $60 (+2% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CBSHEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.3%
Equity Research

Texas Capital Bancshares, Inc. (TCBI)

HOLD. 12-month probability-weighted target $105 (+7% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

TCBIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.4%
Equity Research

Home BancShares Inc (HOMB)

HOLD. 12-month probability-weighted target $30 (-1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HOMBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.5%
Equity Research

Aon PLC (AON)

HOLD. 12-month probability-weighted target $325 (+3% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AONEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.6%
Equity Research

Reinsurance Group of America (RGA)

HOLD. 12-month probability-weighted target $233 (-6% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

RGAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.1%
Equity Research

Shift4 Payments Inc (FOUR)

HOLD. 12-month probability-weighted target $51 (+20% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

FOUREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.3%
Equity Research

Franklin Resources Inc (BEN)

HOLD. 12-month probability-weighted target $33 (-5% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

BENEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.3%
Equity Research

Valley National Bancorp (VLY)

HOLD. 12-month probability-weighted target $15 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

VLYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.5%
Equity Research

Charles Schwab Corp (SCHW)

SELL. 12-month probability-weighted target $91 (-15% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

SCHWEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -8.6%
Equity Research

Carlyle Group Inc (CG)

HOLD. 12-month probability-weighted target $44 (-5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.6%
Equity Research

Synchrony Financial (SYF)

HOLD. 12-month probability-weighted target $75 (-5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SYFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -9.4%
Equity Research

Erie Indemnity Company (ERIE)

HOLD. 12-month probability-weighted target $241 (-1% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

ERIEEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -9.5%
Equity Research

MSCI Inc (MSCI)

HOLD. 12-month probability-weighted target $550 (+0% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

MSCIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.0%
Equity Research

M&T Bank Corporation (MTB)

HOLD. 12-month probability-weighted target $248 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

MTBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.1%
Equity Research

Truist Financial Corp (TFC)

HOLD. 12-month probability-weighted target $50 (-1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

TFCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.2%
Equity Research

S&P Global Inc (SPGI)

HOLD. 12-month probability-weighted target $397 (-7% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

SPGIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.3%
Equity Research

U.S. Bancorp (USB)

HOLD. 12-month probability-weighted target $60 (-5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

USBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.3%
Equity Research

Arthur J Gallagher & Co (AJG)

SELL. 12-month probability-weighted target $219 (-13% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

AJGEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -10.4%
Equity Research

Apollo Global Management LLC Class A (APO)

SELL. 12-month probability-weighted target $113 (-14% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

APOEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -10.6%
Equity Research

Loews Corp (L)

HOLD. 12-month probability-weighted target $112 (+4% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

LEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.7%
Equity Research

Huntington Bancshares Incorporated (HBAN)

HOLD. 12-month probability-weighted target $18 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HBANEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.8%
Equity Research

Moodys Corporation (MCO)

HOLD. 12-month probability-weighted target $457 (-5% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

MCOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.0%
Equity Research

Hancock Whitney Corp (HWC)

HOLD. 12-month probability-weighted target $77 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HWCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.1%
Equity Research

Wells Fargo & Company (WFC)

HOLD. 12-month probability-weighted target $84 (-5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

WFCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.4%
Equity Research

SEI Investments Company (SEIC)

HOLD. 12-month probability-weighted target $101 (-7% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

SEICEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.5%
Equity Research

Corpay Inc (CPAY)

SELL. 12-month probability-weighted target $344 (-15% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

CPAYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -11.5%
Equity Research

PNC Financial Services Group Inc (PNC)

HOLD. 12-month probability-weighted target $238 (-2% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PNCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.3%
Equity Research

American International Group Inc (AIG)

HOLD. 12-month probability-weighted target $72 (-4% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

AIGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.4%
Equity Research

United Bankshares Inc (UBSI)

HOLD. 12-month probability-weighted target $49 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

UBSIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.5%
Equity Research

Prudential Financial, Inc. (PRU)

SELL. 12-month probability-weighted target $105 (-12% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

PRUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -12.6%
Equity Research

Capital One Financial Corporation (COF)

HOLD. 12-month probability-weighted target $196 (-8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

COFEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.6%
Equity Research

Voya Financial Inc (VOYA)

HOLD. 12-month probability-weighted target $102 (-1% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

VOYAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.8%
Equity Research

Marsh & McLennan Companies, Inc. (MRSH)

HOLD. 12-month probability-weighted target $172 (-5% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

MRSHEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -13.8%
Equity Research

Mastercard Inc (MA)

SELL. 12-month probability-weighted target $499 (-13% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

MAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -14.0%
Equity Research

Principal Financial Group Inc (PFG)

HOLD. 12-month probability-weighted target $106 (-8% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

PFGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.2%
Equity Research

Cullen/Frost Bankers Inc (CFR)

HOLD. 12-month probability-weighted target $159 (-3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CFREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.6%
Equity Research

Morgan Stanley (MS)

HOLD. 12-month probability-weighted target $202 (-6% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

MSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.8%
Equity Research

Jack Henry & Associates Inc (JKHY)

SELL. 12-month probability-weighted target $132 (-17% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

JKHYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -15.0%
Equity Research

Ryan Specialty Group Holdings Inc (RYAN)

HOLD. 12-month probability-weighted target $43 (+5% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

RYANEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -15.3%
Equity Research

The Travelers Companies Inc (TRV)

SELL. 12-month probability-weighted target $318 (-13% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

TRVEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -15.8%
Equity Research

JPMorgan Chase & Co. (JPM)

SELL. 12-month probability-weighted target $294 (-17% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

JPMEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -16.1%
Equity Research

Ameriprise Financial Inc (AMP)

SELL. 12-month probability-weighted target $423 (-24% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

AMPEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -16.2%
Equity Research

Visa Inc. Class A (V)

HOLD. 12-month probability-weighted target $339 (-8% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

VEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -16.5%
Equity Research

Hamilton Lane Inc (HLNE)

SELL. 12-month probability-weighted target $84 (-17% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

HLNEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.1%
Equity Research

Cboe Global Markets Inc (CBOE)

SELL. 12-month probability-weighted target $235 (-20% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBOEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.7%
Equity Research

Prosperity Bancshares Inc (PB)

HOLD. 12-month probability-weighted target $74 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -17.8%
Equity Research

Citigroup Inc. (C)

HOLD. 12-month probability-weighted target $145 (+6% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -18.2%
Equity Research

FactSet Research Systems Inc (FDS)

SELL. 12-month probability-weighted target $236 (-18% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

FDSEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.7%
Equity Research

Brown & Brown Inc (BRO)

SELL. 12-month probability-weighted target $63 (-8% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

BROEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.7%
Equity Research

Bank of America Corp (BAC)

HOLD. 12-month probability-weighted target $57 (-8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BACEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -19.0%
Equity Research

Global Payments Inc (GPN)

SELL. 12-month probability-weighted target $70 (-21% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

GPNEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -19.7%
Equity Research

BlackRock Inc (BLK)

SELL. 12-month probability-weighted target $930 (-15% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

BLKEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -20.0%
Equity Research

MetLife Inc (MET)

SELL. 12-month probability-weighted target $84 (-12% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

METEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -20.0%
Equity Research

Northern Trust Corporation (NTRS)

HOLD. 12-month probability-weighted target $176 (-5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

NTRSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -20.5%
Equity Research

CNO Financial Group Inc (CNO)

HOLD. 12-month probability-weighted target $55 (-1% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

CNOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -21.3%
Equity Research

Morningstar Inc (MORN)

SELL. 12-month probability-weighted target $169 (-16% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

MORNEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.4%
Equity Research

Citizens Financial Group, Inc. (CFG)

HOLD. 12-month probability-weighted target $71 (+2% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CFGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -21.4%
Equity Research

Blackstone Group Inc (BX)

SELL. 12-month probability-weighted target $115 (-14% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

BXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.6%
Equity Research

Willis Towers Watson PLC (WTW)

SELL. 12-month probability-weighted target $271 (-17% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

WTWEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.8%
Equity Research

Invesco Plc (IVZ)

SELL. 12-month probability-weighted target $26 (-19% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

IVZEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -22.0%
Equity Research

Fidelity National Information Services Inc (FIS)

HOLD. 12-month probability-weighted target $38 (-3% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

FISEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -22.2%
Equity Research

Goldman Sachs Group Inc (GS)

HOLD. 12-month probability-weighted target $1005 (-3% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

GSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -23.0%
Equity Research

Nasdaq Inc (NDAQ)

SELL. 12-month probability-weighted target $82 (-14% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

NDAQEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -23.8%
Equity Research

State Street Corp (STT)

SELL. 12-month probability-weighted target $169 (-12% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

STTEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -24.0%
Equity Research

First Financial Bankshares Inc (FFIN)

SELL. 12-month probability-weighted target $28 (-14% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FFINEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -26.4%
Equity Research

Fifth Third Bancorp (FITB)

HOLD. 12-month probability-weighted target $51 (-6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FITBEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -27.5%
Equity Research

The Bank of New York Mellon Corporation (BNY)

SELL. 12-month probability-weighted target $141 (-13% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

BNYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.2%
Equity Research

Unum Group (UNM)

HOLD. 12-month probability-weighted target $86 (-8% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

UNMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -28.7%
Equity Research

CME Group Inc (CME)

SELL. 12-month probability-weighted target $217 (-22% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

CMEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.8%
Equity Research

Wex Inc (WEX)

SELL. 12-month probability-weighted target $157 (-16% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

WEXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -31.6%
Equity Research

Intercontinental Exchange Inc (ICE)

SELL. 12-month probability-weighted target $123 (-22% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

ICEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -31.6%
Equity Research

Affiliated Managers Group, Inc. (AMG)

SELL. 12-month probability-weighted target $282 (-22% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

AMGEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -31.9%
Equity Research

FirstCash Inc (FCFS)

HOLD. 12-month probability-weighted target $206 (-8% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

FCFSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -32.0%
Equity Research

KKR & Co. Inc. (KKR)

SELL. 12-month probability-weighted target $88 (-17% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

KKREquity ResearchMonte Carlo
9 September 2026Rating: SELL · -39.0%
Equity Research

Ares Management LP (ARES)

SELL. 12-month probability-weighted target $105 (-24% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

ARESEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -40.5%
Equity Research

Flagstar Financial, Inc. (FLG)

SELL. 12-month probability-weighted target $11 (-19% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

FLGEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -41.1%
Equity Research

Robinhood Markets (HOOD)

SELL. 12-month probability-weighted target $79 (-32% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

HOODEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -44.8%
Equity Research

Coinbase Global Inc (COIN)

SELL. 12-month probability-weighted target $117 (-35% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

COINEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -46.9%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed